ghk cu inhibits 5 alpha reductase dht 5-Alpha-Reductase Inhibitor - an overview Metabolism pathways for deactivation of

Subcutaneous injection sites commonly include the abdomen (avoiding the navel area), outer thigh, or upper arm

Avoid the immediate eye area unless your product is specifically formulated for eye use

Less Common Mild headache Temporary skin purging (topical) These typically resolve with continued use or dose adjustment

Target Ther

Proposed mechanisms of AOD-9604: Stimulates lipolysis (fat breakdown) Increases fat oxidation Promotes mobilization of stored fat Influences lipid metabolism Importantly, AOD-9604 does not appear to significantly increase growth hormone levels, IGF-1 levels, water retention, or organ growth